Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLS | PBYI | ABEO | ||
| Company | Sellas Life Sciences Group Inc | Puma Biotechnology | Abeona Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.03 | 5.82 | 5.09 | ||
| High | 2.17 | 5.90 | 5.13 | ||
| Low | 2.03 | 5.62 | 5.04 | ||
| Latest | 2.10 | 5.67 | 5.07 | ||
| Change | +0.06 | -0.15 | -0.01 | ||
| % Change | +2.94% | -2.58% | -0.20% | ||
| Volume | 2,056,415 | 79,149 | 273,108 | ||
| 20-Day Average Volume | 4,531,384 | 384,033 | 1,450,201 | ||
| Previous Close | 2.04 | 5.82 | 5.08 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.70 | 5.24 | 4.89 | ||
| 20-Day Raw Stochastic | 92.26% | 74.55% | 64.01% | ||
| 20-Day Relative Strength | 63.61 | 57.43 | 51.18 | ||
| Weighted Alpha | +63.98 | +53.85 | -16.19 | ||
| Today's Opinion | 72% Buy | 100% Buy | 56% Sell | ||
| Previous Opinion | 72% Buy | 100% Buy | 48% Sell | ||
| Last Month's Opinion | 40% Sell | 64% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.79% since 12/09/25 | +1.99% since 12/09/25 | -2.96% since 12/09/25 | ||
| Low | 1.84 on 12/10/25 | 5.43 on 12/10/25 | 5.00 on 12/15/25 | ||
| High | 2.16 on 12/16/25 | 5.91 on 12/15/25 | 5.61 on 12/10/25 | ||
| 1-Month | |||||
| %Chg | +47.20% since 11/14/25 | +15.13% since 11/14/25 | +14.27% since 11/14/25 | ||
| Low | 1.39 on 12/02/25 | 4.80 on 11/20/25 | 4.16 on 11/20/25 | ||
| High | 2.16 on 12/16/25 | 5.91 on 12/15/25 | 5.61 on 12/10/25 | ||
| 3-Month | |||||
| %Chg | +26.05% since 09/16/25 | +24.56% since 09/16/25 | -10.48% since 09/16/25 | ||
| Low | 1.39 on 12/02/25 | 4.30 on 09/17/25 | 4.00 on 11/07/25 | ||
| High | 2.48 on 10/20/25 | 6.12 on 11/10/25 | 5.82 on 09/17/25 | ||
| 6-Month | |||||
| %Chg | +30.75% since 06/16/25 | +63.19% since 06/16/25 | -14.75% since 06/16/25 | ||
| Low | 1.39 on 12/02/25 | 3.03 on 08/01/25 | 4.00 on 11/07/25 | ||
| High | 2.48 on 10/20/25 | 6.12 on 11/10/25 | 7.54 on 08/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 290,582 | 293,276 | 275,290 | ||
| Shares Outstanding, K | 142,442 | 50,391 | 54,191 | ||
| Annual Sales | 0 | 230,470,000 | 0 | ||
| Annual Net Income | -30,880,000 | 30,280,000 | -63,730,000 | ||
| Last Quarter Sales | 0 | 54,480,000 | 400,000 | ||
| Last Quarter Net Income | -6,790,000 | 8,840,000 | 108,830,000 | ||
| 60-Month Beta | 2.51 | 1.18 | 1.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/12/25 | 0.21 on 11/06/25 | -0.10 on 11/12/25 | ||
| Latest Earnings Date | 03/19/26 | 02/26/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 7.92 | 4.74 | ||